Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

Market Cap	603.46B
Revenue (ttm)	222.50B
Net Income (ttm)	-13.51B
Shares Out	51.26M
EPS (ttm)	-265.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	459,129
Average Volume	1,103,810
Open	11,310
Previous Close	11,220
Day's Range	10,800 - 11,430
52-Week Range	6,400 - 19,750
Beta	2.13
RSI	61.21
Earnings Date	May 14, 2025

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1962
• Employees: 819
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 019170

Financial Performance

In 2024, KRX:019170's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.